Zobrazeno 1 - 10
of 48
pro vyhledávání: '"De, Pieter"'
Autor:
De Azevedo, Antonio Expedito Gomes, Sánchez, Antonio Santos, Tondo, Carine, Alves Douglas, Bitencourt Vidal, Ednildo Andrade, Torres Fábio, Matos Fernandes, Gaudêncio, Francisco, Mendonça Freires, Alexandre, José, Ferraz De, Andrade Santos, Ricardo, José, Uchoa Cavalcanti, Almeida Luís, Silva, Oscar, Martins Milton, Porsani, José, Ferreira, Paulo Roberto, Moura Bastos, De, Pieter, Kleber, Jong, Freire Da Silva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a954d5188f42607ad91e02d420a1b2ab
Autor:
de Pieter Taeke Boer
Ouderen hebben een verhoogd risico op complicaties en overlijden na een infectieziekte. Vaccineren kan ziektelast voorkomen, maar het gezondheidszorgbudget is beperkt. In dit proefschrift wordt gekeken naar de kosten en effecten van verschillende vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b64ae72f4062622d372522bfacfab50
https://doi.org/10.33612/diss.126806948
https://doi.org/10.33612/diss.126806948
Autor:
Franklin C.K. Dolk, Alexander W. Friedrich, Jan Wilschut, de Pieter Boer, R Pitman, BM van Maanen, Maarten J. Postma
Publikováno v:
Expert review of vaccines, 16(1), 1-4. TAYLOR & FRANCIS LTD
Influenza is an acute respiratory infection primarily caused by influenza virus types A or B [1]. Next to occasional pandemics, influenza virus causes annual seasonal outbreaks. Globally, these ann...
Autor:
de Pieter Graeff, Peter G. M. Mol, Sigrid Piening, Sabine M. J. M. Straus, Jaap E. Wieringa, K. Reber, Flora M. Haaijer-Ruskamp
Publikováno v:
Clinical Pharmacology & Therapeutics, 91(5), 838-845. Wiley-Blackwell
Clinical Pharmacology & Therapeutics, 91(5), 838-845. Nature Publishing Group
Clinical Pharmacology & Therapeutics, 91(5), 838-845. Nature Publishing Group
The effect of Direct Healthcare Professional Communications (DHPCs) informing health-care providers of serious drug safety issues has been questioned. The aim of this study was to evaluate the impact of DHPCs on drug use. Nationwide dispensing data f
Autor:
de Pieter Vries, K. R. van Slochteren
Publikováno v:
Journal of Computational Neuroscience, 25(1), 188-202
Journal of Computational Neuroscience
Journal of Computational Neuroscience
The brain processes underlying cognitive tasks must be very robust. Disruptions such as the destruction of large numbers of neurons, or the impact of alcohol and lack of sleep do not have negative effects except when they occur in an extreme form. Th
Autor:
de Pieter Vries
Publikováno v:
Psychological research-Psychologische forschung, 69(1-2), 41-66. SPRINGER HEIDELBERG
The binding problem requires a solution at the level of individual neurons, but no definite mechanism has yet be given. Therefore, the neuronal level is as yet inadequate for modeling cognitive processes in which binding plays a crucial role. Moreove
Publikováno v:
International Journal for Quality in Health Care, 16(3), 229-236. Oxford University Press
Objectives. joint drug formularies and treatment guidelines have been developed to reduce problems arising at the interface between primary and secondary care. The aim is to compare the willingness of hospital specialists and general practitioners to
Autor:
van Dirk Veldhuisen, de Dick Zeeuw, Diederik E. Grobbee, Hans L. Hillege, van Wiekert Gilst, de Pieter Graeff, Gerarda Navis
Publikováno v:
European Heart Journal, 24(5), 412-420. Oxford University Press
Aims Information regarding the cardiorenal axis in patients after a myocardial infarction (MI) is limited. We examined the change in renal function after a first MI, the protective effect of angiotensin converting enzyme (ACE) inhibition and the prog
Publikováno v:
Blood Pressure, 12, 22-29. Taylor & Francis Group
Background: Experimental and clinical evidence suggests that calcium-channel blockers may retard the atherosclerotic process after long-term treatment. Whether these effects exist after intermediate-term treatment in hypertensive patients is mainly u
Publikováno v:
International Journal of Technology Assessment in Health Care. 17:559-570
Objectives: To study considerations used by professional and academic leaders to assess the position of new cardiovascular drugs in the therapeutic regimen in relationship to professional characteristics and the level of prescribing.Methods: Intervie